MetLife, Inc.METNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 94% recommend buying.

Consensus Rating
Buy
16 analysts·Moderate coverage
94%
Rating Distribution
Strong Buy
00%
Buy
1594%
Hold
16%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 30% higher.

Bear Case
$84.00
+15%
Consensus
$95.00
+30%
Bull Case
$101.00
+38%
Price Range16 analysts
Low
Consensus
High
$84.00
$101.00
Current Target
Current Price
$73.24
Upside to Target
$21.76

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$9.82(10 analysts)
P/E14x
Current: 14.4x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+4.53%
EPS+11.76%
FY2028
Rev+6.06%
EPS+12.32%
FY2029
Rev+5.27%
EPS+4.27%

Earnings Surprises

Beat rate:42%(5/12 quarters)
Avg surprise:-0.9%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 12, 2026Mizuho Securities
MetLife price target lowered to $100 from $102 at Mizuho
Target:$100.00
+26.8%from $78.89
Feb 10, 2026Evercore ISI
MetLife (MET) PT Lowered to $95 at Evercore ISI
Target:$95.00
+21.9%from $77.92
Feb 5, 2026UBS
MetLife price target raised to $98 from $94 at UBS
Target:$98.00
+25.6%from $78.01
Jan 14, 2026Mizuho Securities
MetLife price target raised to $102 from $101 at Mizuho
Target:$102.00
+32.3%from $77.08
Jan 13, 2026Wells Fargo
MetLife price target raised to $97 from $94 at Wells Fargo
Target:$97.00
+23.9%from $78.32
Jan 8, 2026UBS
MetLife price target lowered to $94 from $95 at UBS
Target:$94.00
+17.8%from $79.79
Jan 8, 2026Barclays
MetLife price target lowered to $90 from $98 at Barclays
Target:$90.00
+13.3%from $79.47
Jan 6, 2026Evercore ISI
MetLife downgraded to In Line from Outperform at Evercore ISI
Target:$97.00
+18.6%from $81.77
Dec 15, 2025Mizuho Securities
MetLife initiated with an Outperform at Mizuho
Target:$101.00
+22.2%from $82.62
Dec 15, 2025Morgan Stanley
MetLife price target raised to $101 from $97 at Morgan Stanley
Target:$101.00
+21.4%from $83.22
Oct 8, 2025Barclays
MetLife price target raised to $98 from $93 at Barclays
Target:$98.00
+18.4%from $82.75
Oct 7, 2025Morgan Stanley
MetLife price target raised to $97 from $94 at Morgan Stanley
Target:$97.00
+17.3%from $82.69
Sep 19, 2025Piper Sandler
MetLife downgraded to Neutral from Overweight at Piper Sandler
Target:$84.00
+6.2%from $79.07
Sep 15, 2025Wolfe Research
MetLife initiated with an Outperform at Wolfe Research
Target:$95.00
+18.1%from $80.46
Jul 14, 2025Morgan Stanley
MetLife price target lowered to $98 from $99 at Morgan Stanley
Target:$98.00
+26.1%from $77.75
Apr 2, 2025Piper Sandler
MetLife price target raised to $94 from $92 at Piper Sandler
Target:$94.00
+14.0%from $82.49
Feb 28, 2025Morgan Stanley
MetLife price target raised to $109 from $101 at Morgan Stanley
Target:$109.00
+26.5%from $86.18
Oct 2, 2024Piper Sandler
MetLife price target raised to $92 from $85 at Piper Sandler
Target:$92.00
+12.5%from $81.78
Sep 4, 2024Barclays
Barclays Starts MetLife (MET) at Overweight
Target:$91.00
+17.4%from $77.52
Aug 1, 2024Bank of America Securities
MetLife price target lowered to $96 from $99 at BofA
Target:$96.00
+24.9%from $76.85
Jul 10, 2024Morgan Stanley
MetLife price target raised to $83 from $82 at Morgan Stanley
Target:$83.00
+18.7%from $69.92
May 22, 2024Argus Research
MetLife (MET) PT Raised to $80 at Argus
Target:$80.00
+9.4%from $73.15
May 6, 2024Piper Sandler
MetLife (MET) PT Lowered to $82 at Piper Sandler
Target:$82.00
+15.6%from $70.94
Mar 13, 2024CFRA
MetLife (MET) PT Raised to $77 at CFRA
Target:$77.00
+6.0%from $72.67
Jan 8, 2024Goldman Sachs
Goldman Sachs Upgrades MetLife (MET) to Buy
Target:$80.00
+16.1%from $68.92